---
title: "Humanwell unit Hubei Bio-Pharma Industry Tech Institute wins China approval to start trials of HWS113 injection for chronic pruritus"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/291155336.md"
description: "Hubei Biomedical Industry Technology Research Institute, a unit of Humanwell Healthcare, has received NMPA approval in China to initiate clinical trials for HWS113 injection. The drug targets chronic pruritus, an indication with no currently approved drugs sharing the same target. The company reports cumulative R&D spending of CNY 36 million for this program."
datetime: "2026-06-29T13:42:47.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/291155336.md)
  - [en](https://longbridge.com/en/news/291155336.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/291155336.md)
---

# Humanwell unit Hubei Bio-Pharma Industry Tech Institute wins China approval to start trials of HWS113 injection for chronic pruritus

-   Humanwell unit Hubei Biomedical Industry Technology Research Institute secured NMPA clearance to start China trials of injectable HWS113. \* Program targets chronic pruritus; company flagged no China-approved drug with the same target for this indication. \* Cumulative R&D spending reached CNY 36 million. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Humanwell Healthcare (Group) Co. Ltd. published the original content used to generate this news brief on June 26, 2026, and is solely responsible for the information contained therein. © Copyright 2026 - Public Technologies (PUBT) Original Document: here

### Related Stocks

- [600079.CN](https://longbridge.com/en/quote/600079.CN.md)

## Related News & Research

- [Humanwell unit Yichang Renfu wins China nod for labor pain trial of sufentanil injection](https://longbridge.com/en/news/295637927.md)
- [11:47 ETNorthwestern Mutual Named Among Nation's Top Independent Broker-Dealers by Financial Planning Magazine](https://longbridge.com/en/news/296250871.md)
- [Insilico Medicine plans joint venture with Pudong Construction to launch RMB 1.01 billion biopharma fund](https://longbridge.com/en/news/296207653.md)
- [15:26 ETVero Fiber and MontanaSky Unite to Create Northwest Montana's Premier Fiber Broadband Provider](https://longbridge.com/en/news/296262298.md)
- [07:20 ETAizen Enters into Collaboration with San Diego Biopharma to Advance Oral Biologics](https://longbridge.com/en/news/296000080.md)